| BID | 1.40 | ASK | 1.50 | ||
| Open | 1.42 | Previous Close | 1.43 | ||
| Pre-Market | - | After-Market | 1.50 | ||
| - - | 0.07 4.90% |
| Target Price | 15.00 | Analyst Rating | Moderate Buy 2.00 | |
| Potential % | 948.95 | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | — - | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★★★★+ — - | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 2.63 | Earnings Rating | Strong Buy | |
| Market Cap | 66.11M | Earnings Date | 6th Apr 2023 | |
| Alpha | -0.02 | Standard Deviation | 0.40 | |
| Beta | 0.43 |
Today's Price Range 1.421.53 | 52W Range 1.229.20 | 5 Year PE Ratio Range -0.6000-1.40 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | 8.33% | ||
| 1 Month | -55.17% | ||
| 3 Months | -35.00% | ||
| 6 Months | 393.10% | ||
| 1 Year | 268.56% | ||
| 3 Years | 23.28% | ||
| 5 Years | -77.08% | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -62.11 | |||
ROE last 12 Months | -45.22 | |||
ROA (5Y Avg) | -18.26 | |||
ROA last 12 Months | -41.39 | |||
ROC (5Y Avg) | -53.05 | |||
ROC last 12 Months | -40.52 | |||
Return on invested Capital Q | -9.86 | |||
Return on invested Capital Y | -10.21 | |||
Assets Turnover | 0.00 | |||
Receivables Turnover | - |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -0.70 | ||||
| 0.34 | ||||
| - | ||||
| - | ||||
| -1.00 | ||||
| -3.51 | ||||
| 0.34 | ||||
| 7.75 | ||||
| -29 129 000.00 | ||||
| Forward PE | -0.48 | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 11.90 | ||||
| 12.10 | ||||
| 0.02 | ||||
| 0.02 | ||||
| -1 861.10 | ||||
| Leverage Ratio | 1.10 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| - |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.00 | ||||
| 0.00 | ||||
| - | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q04 2022 | -0.68 | -0.64 | 5.88 |
| Q03 2022 | -0.90 | -0.04 | 95.56 |
| Q02 2022 | -1.00 | -0.80 | 20.00 |
| Q01 2022 | -1.20 | -1.20 | 0.00 |
| Q04 2021 | - | -1.20 | - |
| Q03 2021 | -1.00 | -0.80 | 20.00 |
| Q02 2021 | -1.00 | -1.20 | -20.00 |
| Q01 2021 | -0.06 | -0.05 | 16.67 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 12/2022 QR | -0.68 | 24.44 | Positive |
| 12/2022 FY | -3.73 | -6.57 | Negative |
| 3/2023 QR | -1.03 | -3.00 | Negative |
| 12/2023 FY | -2.75 | 16.67 | Positive |
| Next Report Date | 6th Apr 2023 |
| Estimated EPS Next Report | -0.68 |
| Estimates Count | 2 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 26.91K |
| Shares Outstanding | 46.23K |
| Shares Float | 116.28M |
| Trades Count | 186 |
| Dollar Volume | 39.59K |
| Avg. Volume | 66.74K |
| Avg. Weekly Volume | 63.77K |
| Avg. Monthly Volume | 72.74K |
| Avg. Quarterly Volume | 63.72K |
Check-Cap Ltd. (NASDAQ: CHEK) stock closed at 1.43 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 26.91K shares and market capitalization of 66.11M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 64 people. Check-Cap Ltd. CEO is Alex Ovadia.
The one-year performance of Check-Cap Ltd. stock is 268.56%, while year-to-date (YTD) performance is -35%. CHEK stock has a five-year performance of -77.08%. Its 52-week range is between 1.22 and 9.198, which gives CHEK stock a 52-week price range ratio of 2.63%
Check-Cap Ltd. currently has a PE ratio of -0.70, a price-to-book (PB) ratio of 0.34, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -41.39%, a ROC of -40.52% and a ROE of -45.22%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.
Of the last four earnings reports from Check-Cap Ltd., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.68 for the next earnings report. Check-Cap Ltd.’s next earnings report date is 06th Apr 2023.
The consensus rating of Wall Street analysts for Check-Cap Ltd. is Moderate Buy (2), with a target price of $15, which is +948.95% compared to the current price. The earnings rating for Check-Cap Ltd. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Check-Cap Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Check-Cap Ltd. has a Sell technical analysis rating based on Technical Indicators (ADX : 25.75, ATR14 : 0.28, CCI20 : -73.84, Chaikin Money Flow : -0.35, MACD : -0.52, Money Flow Index : 21.67, ROC : -50.52, RSI : 27.12, STOCH (14,3) : 10.35, STOCH RSI : 0.85, UO : 38.04, Williams %R : -89.65), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Check-Cap Ltd. in the last 12-months were:
Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection.
CEO: Alex Ovadia
Telephone: +972 48303401
Address: 29 Abba Hushi Avenue, Isfiya 3009000, , IL
Number of employees: 64
